Yokohama, Japan

Takeo Miyaki



Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 159(Granted Patents)


Location History:

  • Yokohama, JA (1976)
  • Yokohoma, JP (1982)
  • Kohoku-ku, Yokohama, JP (1991)
  • Yokohama, JP (1981 - 1998)

Company Filing History:


Years Active: 1976-1998

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: Innovations of Takeo Miyaki: A Pioneer in Antifungal and Antiviral Antibiotics

Introduction

Takeo Miyaki, based in Yokohama, Japan, is a distinguished inventor with an impressive portfolio of 35 patents. His groundbreaking work primarily focuses on the development of novel antifungal and antiviral antibiotics. His inventions have made significant contributions to the fields of microbiology and pharmaceuticals, addressing pressing health challenges through innovative solutions.

Latest Patents

Among Takeo Miyaki's most recent patents are the groundbreaking pradimicins L and FL, as well as derivatives thereof. These inventions represent a new class of antifungal antibiotics produced by the Actinomadura verrucosospora subsp. neohibisca strain R103-3, ATCC No. 53930. In addition, he has developed an antiviral antibiotic, BU-3889V, which consists of a complex formed through the fermentation of the new microorganism Amycolatopsis orientalis ATCC-53884. The bioactive components A.sub.1, A.sub.2, A.sub.3, D.sub.1, D.sub.2, and D.sub.3 showcase promising efficacy in inhibiting various viruses, including herpes simplex virus, human immunodeficiency virus (HIV), and the influenza virus.

Career Highlights

Throughout his esteemed career, Takeo Miyaki has worked with notable companies such as Bristol-Myers Company and Bristol-Myers Squibb Company. His extensive experience in the pharmaceutical industry has enabled him to advance his research and development efforts, leading to significant innovations in antibiotic therapies.

Collaborations

Takeo Miyaki has collaborated with talented professionals in his field, including Masataka Konishi and Toshikazu Oki. These partnerships have contributed to the success of his innovations and have played a pivotal role in the development of his patented products.

Conclusion

Takeo Miyaki's contributions to the fields of pharmaceuticals and microbiology are both innovative and impactful. His latest patents, focusing on antifungal and antiviral antibiotics, exemplify his commitment to addressing critical health issues through science and research. As he continues to push the boundaries of innovation, Takeo Miyaki remains a prominent figure in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…